New cancer drug enters human testing
NCT ID NCT04349267
Summary
This early-phase study tested a new drug called BMS-986315, both by itself and combined with other cancer treatments, in people with advanced solid tumors. The main goals were to check the safety of the drug and see if it showed any signs of helping to shrink tumors. The study involved 44 participants with specific advanced cancers who had already tried standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Local Institution
Mexico City, Mexico City, 06100, Mexico
-
Local Institution - 0001
Germantown, Tennessee, 38138, United States
-
Local Institution - 0004
Toronto, Ontario, M5G 2M9, Canada
-
Local Institution - 0005
Montreal, Quebec, H2X 3E4, Canada
-
Local Institution - 0011
Vancouver, British Columbia, V5Z 4E6, Canada
-
Local Institution - 0013
Ottawa, K1H 8L6, Canada
-
Local Institution - 0014
Edmonton, Alberta, T6X 1E8, Canada
-
Local Institution - 0028
Sioux Falls, South Dakota, 57104, United States
Conditions
Explore the condition pages connected to this study.